Evidence map›Paper›PMID 30443685›Full record

ArticleChemistry Central journal2018

Green multicomponent synthesis, antimicrobial and antioxidant evaluation of novel 5-amino-isoxazole-4-carbonitriles.

Hamid Beyzaei, Mahboubeh Kamali Deljoo, Reza Aryan, Behzad Ghasemi, Mohammad Mehdi Zahedi, Mohammadreza Moghaddam-Manesh

Abstract read
In one paragraph

Article in Chemistry Central journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Methanol extract of Iraqi Kurdistan RegionFrontiers in chemistry · 2023
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hamid BeyzaeiDepartment of Chemistry, Faculty of Science, University of Zabol, Zabol, Iran. hbeyzaei@yahoo.com.ORCID http://orcid.org/0000-0002-6824-1367
Mahboubeh Kamali DeljooDepartment of Chemistry, Faculty of Science, University of Zabol, Zabol, Iran.
Reza AryanDepartment of Chemistry, Faculty of Science, University of Zabol, Zabol, Iran.
Behzad GhasemiTorbat Jam Faculty of Medical Sciences, Torbat Jam, Iran.
Mohammad Mehdi ZahediDepartment of Chemistry, University of Saskatchewan, 110 Science Place, Saskatoon, SK, S7N 5C9, Canada.
Mohammadreza Moghaddam-ManeshYoung Researchers and Elite Club, Kerman Branch, Islamic Azad University, Kerman, Iran.

Funding

University of Zabol UOZ-GR-9517-15
6 · The paper itself

Abstract

backgroundDesign and synthesis of new inhibitor agents to deal with pathogenic microorganisms is expanding. In this project, an efficient, environmentally friendly, economical, rapid and mild procedure was developed for the synthesis of novel functionalized isoxazole derivatives as antimicrobial potentials.

methodsMulticomponent reaction between malononitrile (1), hydroxylamine hydrochloride (2) and different aryl or heteroaryl aldehydes 3a-i afforded novel 5-amino-isoxazole-4-carbonitriles 4a-i in good product yields and short reaction times. Deep eutectic solvent K

resultsBroad-spectrum antimicrobial activities were observed with isoxazoles 4a, b, d. In addition, antioxidant activity of isoxazole 4i was proven on DPPH.

conclusionsIn this project, compounds 4a, b, d could efficiently inhibit the growth of various bacterial and fungal pathogens. Antioxidant properties of derivative 4i were also significant. These biologically active compounds are suitable candidates to synthesize new prodrugs and drugs due to the presence of different functional groups on their rings.

Indexed as

Antibacterial activityAntifungal propertyAntioxidant effectIsoxazoleMulticomponent synthesis

Identifiers

PMID30443685
PMCPMC6768021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.